Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies von WONG, P. C., CRAIN, E. J., XIN, B., WEXLER, R. R., LAM, P. Y. S., PINTO, D. J., LUETTGEN, J. M., KNABB, R. M.

Volltext

Bisbenzamidine isoxazoline derivatives as factor Xa inhibitors von Quan, M.L., Pruitt, J.R., Ellis, C.D., Liauw, A.Y., Galemmo, R.A., Stouten, P.F.W., Wityak, J., Knabb, R.M., Thoolen, M.J., Wong, P.C., Wexler, R.R.

Volltext

S 1 heterocyclic thrombin inhibitors von Dominguez, C, Carini, D.J, Weber, P.C, Knabb, R.M, Alexander, R.S, Kettner, C.A, Wexler, R.R

Volltext

S1 heterocyclic thrombin inhibitors von DOMINGUEZ, C, CARINI, D. J, WEBER, P. C, KNABB, R. M, ALEXANDER, R. S, KETTNER, C. A, WEXLER, R. R

Volltext

Biaryl substituted alkylboronate esters as thrombin inhibitors von Quan, M.L., Wityak, J., Dominguez, C., Duncia, J.V., Kettner, C.A., Ellis, C.D., Liauw, A.Y., Park, J.M., Santella, J.B., Knabb, R.M., Thoolen, M.J., Weber, P.C., Wexler, R.R.

Volltext

Vitronectin effects on recombinant plasminogen activator inhibitor-1: structural and functional analysis von Reilly, T.M., Forsythe, M.S., Dwivedi, A.M., Walton, H.L., Duke, J.L., Wade, D.L., Knabb, R.M., Mousa, S.A.

Volltext